1. Aurobindo Pharma Limited
7/23/2018
Chemistry support for
building partnerships
CTX LIFESCIENCES PVT LTD
An integrated Partner throughout API Cycle
US FDA/EU GMP Certified/PMDA Accreditation and compliant

2. Aurobindo Pharma Limited
7/23/2018
Who we are
Colourtex, a 40-year old largest dyes and intermediates company in India with over 2000 employees and annual revenues of USD 250 millions, diversified into Pharmaceuticals in 2004
Privately held Company headquartered in Surat, 260 kms north of Mumbai. Surat - a major hub for Chemicals and Diamonds
Commercial production started in the state-of-the-art green-field facility during second quarter of 2006
Presence in anti-infectives, CVS, CNS, anti-diabetes and other segments

3. Aurobindo Pharma Limited
7/23/2018
Our Vision
To be the preferred strategic partner for the pharmaceutical industry and share responsibilities & goals for the enhancement of human health.

4. Aurobindo Pharma Limited
7/23/2018
Our Mission
To develop and manufacture Active Pharmaceutical Ingredients and Intermediates for global supply complying to quality and regulatory requirements of our customers.

5. Aurobindo Pharma Limited
7/23/2018
Our Mfg Strengths and Plans
US FDA inspected and compliant facility, EUGMP Certified andJapan Accredited with over 200,000 sq.ft area spread on 38 acres of land. One facility for all markets. Large intermediate plant.
Cost effective operating structure with vertical integration in some products
Skilled workforce and competent technical & management team with global and global pharma experience
Total number of reactors : 83 Nos.
Total reactors volume : 220 meter cube
Total number of people : 296

6. Aurobindo Pharma Limited
7/23/2018
Our Mfg Strengths and Plans
Access to own large infrastructure, viz. water reservoirs, power generation, effluent treatment plant, landfill site and incinerators. Also, large intermediate plant
Can handle complex chemical reactions viz., cynation, nitration, chlorosulfonation, hydrogenation and ethoxylation
Investment over USD 27 millions
US DMF filed for 16 products and three approved. CEP filed for 9 products and seven approved.
Validations completed for Olmesartan and Pregabalin and planned for Candesartan and Quetiapine

7. Aurobindo Pharma Limited
7/23/2018
Product Range
Amiodarone
Alendronate Sodium
Acetazolamide
Carvedilol
Chlorothiazide
Carbamazepine
Hydrochlorothiazide
Irbesartan
Lamotrigine
Metoprolol Tartrate/Succinate
Olmesartan
Oxcarbazepine
Oxymetazoline/Xylometazoline
Pregabalin
Terbinafine
Terazosin
Sevelamer Hcl
Colesevelam
Candesartan

8. Why partner with CTX Lifesciences
Aurobindo Pharma Limited
7/23/2018
Why partner with CTX Lifesciences
Chemistry competence over thirty years
Excellent infrastructure viz. water, power, disposal of gaseous, liquid and solid organic wastes and financial strength
cGMP compliant state of the art facility with focus on API and Intermediates. Facility audited by Astra Zeneca, Glaxo, Novartis, EMerck, Aventis,, Teva, Mylan, Sandoz, Actavis, Siegfried, Pliva and visit by Pfizer and found to comply their requirements.
US FDA inspected and compliant facility; PMDA accreditation and EUGMP Certified.
Plan to file at least 5 DMFs in 2012
Experienced technical and commercial team with global and global pharma experience.
Vertical integration on Hydrochlorothiazide, Xylometazoline, Oxymetazoline, Irbesartan Sevelamer, Colesevalam, and Lamotrigine and working on Metoprolol Tartrate, Succinate and Oxcarbazepine
Environment, Safety and Health Practices

9. Aurobindo Pharma Limited
7/23/2018
Manufacturing and R&D

10. Aurobindo Pharma Limited
7/23/2018
Thank You